![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/06 | |
A61K 38/15 | |||
A61K 47/06 | |||
A61K 47/14 | |||
A61K 9/00 | |||
A61P 17/00 |
(11) | Number of the document | 2699231 |
(13) | Kind of document | T |
(96) | European patent application number | 12723241.1 |
Date of filing the European patent application | 2012-04-18 | |
(97) | Date of publication of the European application | 2014-02-26 |
(45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2012/051946 |
Date | 2012-04-18 |
(87) | Number | WO 2012/143868 |
Date | 2012-10-26 |
(30) | Number | Date | Country code |
201161477297 P | 2011-04-20 | US |
(72) |
HAUG, Claire, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE |
SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE |